# Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tyrosine-kinase-inhibitor-usage-treatment-outcome-and-prognostic-scores-in-cml/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Martin Höglund,Fredrik Sandin,Karin Hellström,Mats Björeman,Magnus Björkholm,Mats Brune,Arta Dreimane,Marja Ekblom,Sören Lehmann,Per Ljungman,Claes Malm,Berit Markevärn,Kristina Myhr‐Eriksson,Lotta Ohm,Ulla Olsson‐Strömberg,Anders Själander,Hans Wadenvik,Bengt Simonsson,Leif Stenke,Johan Richter |
| Citations | 127 |
| DOI | 10.1182/blood-2013-04-495598 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2018195863 |
| PMID | 23843494 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Karin Hellström](https://scholariq.org/researchers/karin-hellstrom/)

## Paper journal

- [Blood](https://scholariq.org/journals/blood/)

## Paper primary topic

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

## Paper topics

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.